Search
D-RUBICIN 50 MG / 50 ML, Poudre pour usage parentéral
Details
| --- | Description |
|---|---|
| Pack | Boîte unitaire |
| Strength (Dosage) | |
| Laboratory | NOVOPHARMA |
| Ingredients | Doxorubicine |
| Therapeutic class | Antinéoplasique, antibiotique cytotoxique (dérivé d'anthracycline) |
| ATC code | L01DB01 |
| PPH | $27.30 |
| PPV | $41.20 |
| Refundable | Yes |
| Refund base | $41.20 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | - Carcinomes du sein - Sarcomes des os et des parties molles - Maladie de Hodgkin, lymphomes non hodgkiniens - Tumeurs solides de l'enfant - Cancers du poumon - Leucémies aiguës et chroniques - Cancers de la vessie, de l’ovaire, de l'estomac |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem